key: cord-0936160-7shmlx84
authors: Caldaria, Antonio; Conforti, Claudio; Di Meo, Nicola; Dianzani, Caterina; Jafferany, Mohammad; Lotti, Torello; Zalaudek, Iris; Giuffrida, Roberta
title: COVID‐19 and SARS: Differences and similarities
date: 2020-04-30
journal: Dermatol Ther
DOI: 10.1111/dth.13395
sha: 6c26454322af5003feb3bf96dc1fa48fcfb85fd8
doc_id: 936160
cord_uid: 7shmlx84

nan

summarized in Table 1 .

Genomic characterization has shown that SARS-CoV-2 share almost 80% of the genome with SARS-CoV but it contains additional gene regions (10b, 13, 14). 5 

COVID-19 and psoriasis: is it time to limit treatment with immunosuppressants? A call for action

Immune responses in COVID-19 and potential vaccines: lessons learned from SARS and MERS epidemic

Evaluation and Treatment Coronavirus (COVID-19) 2020

Learning from history: coronavirus outbreaks in the past

Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan

COVID-19) outbreak situation

The reproductive number of COVID-19 is higher compared to SARS coronavirus

Systematic comparison of two animal-tohuman transmitted human coronaviruses: SARS-CoV-2 and SARS-CoV

The COVID-19 epidemic